zhong guo yao wu hua xue za zhi tou gao xu zhi

..............page:1-2

Synthesis and in vitro antiplatelet activity of triazolo [4,5-d]pyrimidine derivatives
LIU Bin;ZUO Bin-hai;SUN Chao;CAI Ze-jiang;YAN Ming;School of Pharmaceutical Sciences;SUN YAT-SEN University;Zhuhai Lianbang Pharmaceutical Co.;Ltd.;

..............page:1-7

Synthesis and antiproliferative activity of diaryl ureas possessing tetrahydropyride [4,3-d]pyrimidine
YU Qian-ru;LI Xu;LU Lin-yi;ZHANG Xiang-qian;CAO Rui-fang;ZHAI Xin;Key Laboratory of Structure-Based Drugs Design & Discovery;Ministry of Education;Qinghai Pharmaceutical Factory Co.;Ltd.;

..............page:8-14

Synthesis and evaluation of the antimicrobial activity of 2-imidazole-amyl-1,4-diene-3-ketone derivatives
LIU Chun-li;SHI Ce;LIU Jin-yan;WEI Bing;MAO Fei;XIANG Ming-jie;LI Jian;College of Pharmacy;East China University of Science and Technology;Ruijin Hospital;Shanghai Jiaotong University;School of Medicine;Luwan Branch;Ruijin Hospital;Shanghai Jiaotong University;School of Medicine;

..............page:15-23

Synthesis and anti-breast cancer activity evaluation of 2-cyano-3,12-dioxooleana-1,9( 11)-dien-28-amide derivatives
AI Yong;KANG Feng-hua;HUANG Zhang-jian;PENG Si-xun;ZHANG Yi-hua;Center of Drug Discovery;China Pharmaceutical University;Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases;

..............page:24-28

Improved synthesis of anti-leukemia drug ponatinib
JIANG Shuang;FENG Yu-bing;DING Ke;LU Xiao-yun;Guangzhou Institutes of Biomedicine and Health;Chinese Academy of Sciences;University of Chinese Academy of Sciences;

..............page:29-31+73

The new synthetic method of vortioxetine hydrobromide
XUE Hao;Department of Pharmaceutical Research and Development;Shenyang Huatai Pharmaceutical Co.;Ltd.;

..............page:32-34

zhong guo yao wu hua xue za zhi guan yu tuo zhan bao dao fan wei de tong zhi

..............page:34

Improved synthesis of mirodenafil
SUN Zhao-zhu;FAN Wen-jin;ZHOU Lin-bo;CHEN Guo-liang;Key Laboratory of Structure-Based Drug Design & Discovery;Ministry of Education;

..............page:35-39

Synthesis of related substances of gestodene
TIAN Jin-long;GAO Hu;WU Song;HU Biao;ZHENG Yan;WANG Dong-mei;State Key Laboratory of Bioactive Substances and Functions of Natural Medicines & Ministry of Health Key Laboratory of Biosynthesis of Natural Products;Institute of Materia Medica;Chinese Academy of Medical Sciences & Peking Union Medical College;Beijing Zizhu Pharmaceutical Company Limited;

..............page:40-44

zhong guo yao wu hua xue za zhi geng huan yuan cheng tou gao xi tong de tong zhi

..............page:44

A new process for preparing co-crystal of cilostazol and p-hydroxybenzoic acid
LIN Feng;ZHAO Yu-mei;ZHENG Zhi-bing;LI Song;College of Pharmacy;Guangxi Medical University;Institute of Pharmacology and Toxicology;Academy of Military Medial Science;

..............page:45-49

Isolation and structural identification of the chemical constituents from the rhizomes of Wikstroemia indica
TONG Li-jin;SUN Li-xin;SUN Li-xia;LU Xue-fei;XU Cui-ling;School of Pharmacy;Shenyang Pharmaceutical University;School of Traditional Chinese Materia Medica;Shenyang Pharmaceutical University;

..............page:50-53

Recent advances in CDC25 phosphatase inhibitors as potential agents for cancer therapy( 2008-2014)
SONG Yu-ning;KANG Dong-wei;ZHANG Qing-zhu;ZHAN Peng;LIU Xin-yong;Department of Medicinal Chemistry;School of Pharmaceutical Sciences;Shandong University;Department of Pharmacology;Key Laboratory of Chemical Biology;School of Pharmaceutical Sciences;Shandong University;

..............page:54-65

Advances on anticancer activity of 20(R)-dammarane-3β,12β,20,25-tetrol and its derivatives
GUO Jun-hui;LIU Ya-fei;QU Fan-zhi;ZHAO Yu-qing;School of Traditional Chinese Materia Medica;Shenyang Pharmaceutical University;

..............page:66-73

Graphical synthetic routes to cabazitaxel
XU Yue;ZHANG Fu-rong;HU Chun;

..............page:74-76

Belinostat
li chang heng ; dong jin hua ;

..............page:77

idelalisib
zhang ya lu ; sun tie min ;

..............page:78

Olodaterol
zhang fu rong ; hu chun ;

..............page:79

Empagliflozin
e yi dan ; xu you jun ;

..............page:80

Oritavancin
liu chun chi ; zhao dong mei ;

..............page:81

canagliflozin/metformin·HCl
li rui juan ; cheng mao sheng ;

..............page:82